Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.
Plasma levels of endothelial and B-cell-derived microparticles are restored by fingolimod treatment in multiple sclerosis patients.
Response to: Tocilizumab, neuromyelitis optica (NMO), and multiple sclerosis.
Aquaporin 4, Helicobacter pylori and potential implications for neuromyelitis optica.
Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesions.
Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology.
Cytomegalovirus seropositivity is negatively associated with multiple sclerosis.
Inhibitory saccadic dysfunction is associated with cerebellar injury in multiple sclerosis.
Is MS an inflammatory or primary degenerative disease?
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: Commentary.
Fulminant inflammatory demyelination: long-term course and magnetic resonance imaging findings.
Erythropoietin Levels in Patients with Multiple SclerosisComplicated with Anemia.
Alpha beta-crystallin expression and presentation following infection with murine gammaherpesvirus 68.
Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.
Trait emotional intelligence and inflammatory diseases.
Functional Assessment of Multiple Sclerosis.
Substrate stiffness of endothelial cells directs LFA-1/ICAM-1 interaction: A physical trigger of immune-related diseases?
Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis.
[NMO spectrum disorder].
[Programs for Continuing Medical Education: A session; 6. Advances in basic research and therapy of multiple sclerosis].
Advances in the management of MS symptoms: recently proposed clinical management algorithms.
MS arising during Tocilizumab therapy for rheumatoid arthritis.
[Hepatitis B vaccination and multiple sclerosis: From medical uncertainty to compensation for victims.]
Anxiety in patients with multiple sclerosis: association with disability, depression, disease type and sex.
Cuprizone does not induce CNS demyelination in nonhuman primates.

Pages